BioTel Heart Revenue and Competitors

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • BioTel Heart's estimated annual revenue is currently $75M per year.(i)
  • BioTel Heart's estimated revenue per employee is $130,890

Employee Data

  • BioTel Heart has 573 Employees.(i)
  • BioTel Heart grew their employee count by 9% last year.

CardioNet was just the beginning. Founded on an innovative, patented technology, the result of years of research and development, the company received FDA approval for its core monitoring technology and was the first to provide real-time, heartbeat-by-heartbeat, ECG monitoring, analysis and response, at home or away, 24/7/365. BioTelemetry Healthcare is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. The Company provides cardiologists and electrophysiologists who prefer to use a single source of cardiac monitoring services with a full spectrum of solutions, ranging from the differentiated Mobile Cardiac Outpatient Telemetryâ?¢ (â??MCOTâ?¢â??) service to wEvent, event, Holter, Pacemaker and International normalized ratio (â??INRâ??) monitoring. INR monitoring is a measurement of blood coagulation in the circulatory system and is prescribed for patients on long term anticoagulation therapy.

keywords:N/A

N/A

Total Funding

573

Number of Employees

$75M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BioTel Heart News

2022-03-22 - New Post-cryptogenic Stroke Remote Telemetry Study ...

As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation...

2022-03-22 - Philips BioTel Heart MCOT patch increases detection of atrial ...

The company said the study determined that a 30-day continuous monitoring program using the Philips BioTel Heart MCOT (mobile cardiac outpatient...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$90M600-4%N/A
#2
$147.9M7361%N/A
#3
$159M757-1%N/A
#4
$35M942N/AN/A
#5
$300M9880%$103.8M